Mortality rates associated with infective endocarditis range from 16% to 25%, with the highest rates observed among patients with nosocomial healthcare-associated infective endocarditis.
Pharmacists are increasingly becoming involved in antibiotic surveillance, including e-surveillance methods; formulation of antibiotic-use policies; and day-to-day control of problematic antibiotic use.
Optimal management for severely ill patients with right-sided infective endocarditis (RSIE) remains challenging. The goal of this study was to determine outcome and associated prognostic factors in a population of ICU patients with RSIE.
A large proportion of surgical site infections are caused by organisms resistant to prophylactic antibiotics, with the greatest apparent burden in low- and middle-income countries
In this systematic review and meta-analysis, patients with infective endocarditis with vegetations greater than 10mm in size had significantly increased risk of systemic embolism and mortality.
Although removal of orthopedic implants is considered to be associated with low risk of infection, higher rates of surgical site infection following these procedures have been reported.
A new expert guidance concerning contact precautions for multidrug resistant bacteria has been released.
The prevalence of methicillin-resistant Staphylococcus aureus colonization did not decline after implementation of state-legislated active surveillance among critically ill adults.
Following vascular reconstruction, patients will receive postdischarge care that includes telehealth electronic monitoring.
Oral antibiotics combined with mechanical bowel preparation should be considered for all patients undergoing left-sided colorectal cancer resections.
Researchers concluded that risk of ICU acquired Gram-negative bacteria was low in mechanically ventilated patients receiving selective digestive tract decontamination.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection
- Fluoroquinolone Use May Increase Risk for Aortic Aneurysm and Dissection
- Reduced Risk of Hepatocellular Carcinoma in DAA-Treated HCV Infection
- Paracetamol Overuse During Cold and Flu Season
- C difficile Risk Higher With Stoma Reversal vs Colectomy